AKSH OPTIFIBRE Price to Earning vs. Price to Sales

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>AO</div>
The Drivers Module shows relationships between AKSH OPTIFIBRE's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of AKSH OPTIFIBRE over time as well as its relative position and ranking within its peers. Check out Trending Equities.

Search Current Fundamental Trends

 
Refresh

AKSH OPTIFIBRE Price to Sales vs. Price to Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining AKSH OPTIFIBRE's current stock value. Our valuation model uses many indicators to compare AKSH OPTIFIBRE value to that of its competitors to determine the firm's financial worth.
AKSH OPTIFIBRE is number one stock in price to earning category among related companies. It is number one stock in price to sales category among related companies fabricating about  0.02  of Price to Sales per Price to Earning. The ratio of Price to Earning to Price to Sales for AKSH OPTIFIBRE is roughly  49.93 
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
AKSH OPTIFIBRE 
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
=
13.48 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
AKSH OPTIFIBRE 
P/S 
 = 
MV Per Share 
Revenue Per Share 
=
0.27 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

AKSHOPTFBR Price to Sales Comparison

AKSHOPTFBR Fundamental Comparison

Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page